{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T17:47:14Z","timestamp":1791049634673,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.anndiagpath.2022.152004","type":"journal-article","created":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T12:49:32Z","timestamp":1656593372000},"page":"152004","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Challenges and limitation of MTAP immunohistochemistry in diagnosing desmoplastic mesothelioma\/sarcomatoid pleural mesothelioma with desmoplastic features"],"prefix":"10.1016","volume":"60","author":[{"given":"Prakasit","family":"Sa-ngiamwibool","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Hamasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayuko","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohru","family":"Tsujimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiko","family":"Kasai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenzo","family":"Hiroshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Kushitani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Takeshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunimitsu","family":"Kawahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinori","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Nabeshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.anndiagpath.2022.152004_bb0005","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1200\/JCO.2008.19.8523","article-title":"Malignant pleural mesothelioma","volume":"27","author":"Tsao","year":"2009","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2022.152004_bb0010","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"Suppl 1","key":"10.1016\/j.anndiagpath.2022.152004_bb0015","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.21037\/tlcr.2019.11.11","article-title":"Epidemiology of mesothelioma in the 21st centuries in Europe and the United States, 40 years after restricted\/banned asbestos use","volume":"9","author":"Alpert","year":"2020","journal-title":"Transl Lung Cancer Res"},{"issue":"7","key":"10.1016\/j.anndiagpath.2022.152004_bb0020","first-page":"718","article-title":"Latent period for malignant mesothelioma of occupational origin","volume":"34","author":"Lanphear","year":"1992","journal-title":"J Occup Med"},{"issue":"9483","key":"10.1016\/j.anndiagpath.2022.152004_bb0025","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(05)67025-0","article-title":"Malignant mesothelioma","volume":"366","author":"Robinson","year":"2005","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.anndiagpath.2022.152004_bb0030","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1097\/JTO.0b013e31826915f1","article-title":"Initial analysis of the international association for the study of lung cancer mesothelioma database","volume":"7","author":"Rusch","year":"2012","journal-title":"J Thorac Oncol"},{"issue":"5","key":"10.1016\/j.anndiagpath.2022.152004_bb0035","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1093\/ejcts\/ezy385","article-title":"Combined modality treatment for malignant pleural mesothelioma: a single-centre long-term survival analysis using extrapleural pneumonectomy","volume":"55","author":"Frick","year":"2019","journal-title":"Eur J Cardiothorac Surg"},{"issue":"4","key":"10.1016\/j.anndiagpath.2022.152004_bb0040","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1200\/JOP.17.00012","article-title":"Treatment of malignant pleural mesothelioma: american society of clinical oncology clinical practice guideline summary","volume":"14","author":"Kindler","year":"2018","journal-title":"J Oncol Pract"},{"issue":"1","key":"10.1016\/j.anndiagpath.2022.152004_bb0045","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5858\/arpa.2017-0124-RA","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma: 2017 update of the consensus statement from the international mesothelioma interest group","volume":"142","author":"Husain","year":"2018","journal-title":"Arch Pathol Lab Med"},{"issue":"11","key":"10.1016\/j.anndiagpath.2022.152004_bb0050","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.1097\/PAS.0000000000001565","article-title":"The separation of benign and malignant mesothelial proliferations: new markers and how to use them","volume":"44","author":"Churg","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"Suppl 1","key":"10.1016\/j.anndiagpath.2022.152004_bb0055","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.21037\/tlcr.2019.11.29","article-title":"Application of immunohistochemistry in diagnosis and management of malignant mesothelioma","volume":"9","author":"Chapel","year":"2020","journal-title":"Transl Lung Cancer Res"},{"issue":"17","key":"10.1016\/j.anndiagpath.2022.152004_bb0060","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1158\/1078-0432.CCR-11-2375","article-title":"New strategies in pleural mesothelioma: BAP1 and NF2 as novel targets for therapeutic development and risk assessment","volume":"18","author":"Ladanyi","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.anndiagpath.2022.152004_bb0065","doi-asserted-by":"crossref","first-page":"268","DOI":"10.21037\/tlcr.2017.05.03","article-title":"BAP1, a tumor suppressor gene driving malignant mesothelioma","volume":"6","author":"Cheung","year":"2017","journal-title":"Transl Lung Cancer Res"},{"issue":"11","key":"10.1016\/j.anndiagpath.2022.152004_bb0070","doi-asserted-by":"crossref","first-page":"238","DOI":"10.21037\/atm.2017.04.29","article-title":"Mesothelioma: recent highlights","volume":"5","author":"Carbone","year":"2017","journal-title":"Ann Transl Med."},{"issue":"40","key":"10.1016\/j.anndiagpath.2022.152004_bb0075","doi-asserted-by":"crossref","first-page":"68863","DOI":"10.18632\/oncotarget.20317","article-title":"Diagnostic accuracy of BRCA1-associated protein 1 in malignant mesothelioma: a meta-analysis","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.anndiagpath.2022.152004_bb0080","first-page":"2108","article-title":"Homozygous deletion of CDKN2A and codeletion of the methylthioadenosine phosphorylase gene in the majority of pleural mesotheliomas","volume":"9","author":"Illei","year":"2003","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.anndiagpath.2022.152004_bb0085","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1309\/AJCPT94JVWIHBKRD","article-title":"Diagnostic usefulness of p16\/CDKN2A FISH in distinguishing between sarcomatoid mesothelioma and fibrous pleuritis","volume":"139","author":"Wu","year":"2013","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"10.1016\/j.anndiagpath.2022.152004_bb0090","doi-asserted-by":"crossref","first-page":"632","DOI":"10.5858\/arpa.2012-0108-OA","article-title":"p16 deletion in sarcomatoid tumors of the lung and pleura","volume":"137","author":"Tochigi","year":"2013","journal-title":"Arch Pathol Lab Med"},{"issue":"5","key":"10.1016\/j.anndiagpath.2022.152004_bb0095","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1097\/PAS.0000000000000616","article-title":"BAP1 immunohistochemistry and p16 FISH in the diagnosis of sarcomatous and desmoplastic mesotheliomas","volume":"40","author":"Hwang","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2022.152004_bb0100","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.lungcan.2018.09.019","article-title":"A combination of MTAP and BAP1 immunohistochemistry is effective for distinguishing sarcomatoid mesothelioma from fibrous pleuritis","volume":"125","author":"Kinoshita","year":"2018","journal-title":"Lung Cancer"},{"key":"10.1016\/j.anndiagpath.2022.152004_bb0105","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.lungcan.2016.12.017","article-title":"Immunohistochemical detection of MTAP and BAP1 protein loss for mesothelioma diagnosis: comparison with 9p21 FISH and BAP1 immunohistochemistry","volume":"104","author":"Hida","year":"2017","journal-title":"Lung Cancer"},{"issue":"12","key":"10.1016\/j.anndiagpath.2022.152004_bb0110","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.5858\/arpa.2018-0273-OA","article-title":"Utility of methylthioadenosine phosphorylase compared with BAP1 immunohistochemistry, and CDKN2A and NF2 fluorescence in situ hybridization in separating reactive mesothelial proliferations from epithelioid malignant mesotheliomas","volume":"142","author":"Berg","year":"2018","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"10.1016\/j.anndiagpath.2022.152004_bb0115","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41379-019-0310-0","article-title":"MTAP immunohistochemistry is an accurate and reproducible surrogate for CDKN2A fluorescence in situ hybridization in diagnosis of malignant pleural mesothelioma","volume":"33","author":"Chapel","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2022.152004_bb0120","series-title":"Thoracic tumours: WHO classification of tumours","year":"2021"},{"key":"10.1016\/j.anndiagpath.2022.152004_bb0125","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1440-1843.2011.01957.x","article-title":"Pathology of the pleura: what the pulmonologists need to know","volume":"16","author":"Cagle","year":"2011","journal-title":"Respirology"},{"issue":"9","key":"10.1016\/j.anndiagpath.2022.152004_bb0130","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/pin.12973","article-title":"Genomic-based ancillary assays offer improved diagnostic yield of effusion cytology with potential challenges in malignant pleural mesothelioma","volume":"70","author":"Kinoshita","year":"2020","journal-title":"Pathol Int"},{"issue":"6","key":"10.1016\/j.anndiagpath.2022.152004_bb0135","doi-asserted-by":"crossref","first-page":"e901","DOI":"10.1016\/j.cllc.2018.08.007","article-title":"Survival by histologic subtype of malignant pleural mesothelioma and the impact of surgical resection on overall survival","volume":"19","author":"Verma","year":"2018","journal-title":"Clin Lung Cancer"},{"issue":"1","key":"10.1016\/j.anndiagpath.2022.152004_bb0140","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jss.2015.01.043","article-title":"Impact of mesothelioma histologic subtype on outcomes in the surveillance, epidemiology, and end results database","volume":"196","author":"Meyerhoff","year":"2015","journal-title":"J Surg Res"},{"issue":"2","key":"10.1016\/j.anndiagpath.2022.152004_bb0145","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.lungcan.2014.08.017","article-title":"Systematic review of response rates of sarcomatoid malignant pleural mesotheliomas in clinical trials","volume":"86","author":"Mansfield","year":"2014","journal-title":"Lung Cancer"},{"issue":"3","key":"10.1016\/j.anndiagpath.2022.152004_bb0150","doi-asserted-by":"crossref","first-page":"639","DOI":"10.21037\/tlcr-19-485","article-title":"Preliminary study highlights the potential of immune checkpoint inhibitors in sarcomatoid mesothelioma","volume":"9","author":"Brockwell","year":"2020","journal-title":"Transl Lung Cancer Res"},{"issue":"3","key":"10.1016\/j.anndiagpath.2022.152004_bb0155","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00000478-198204000-00003","article-title":"Desmoplastic diffuse mesothelioma","volume":"6","author":"Cantin","year":"1982","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2022.152004_bb0160","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1186\/s12885-016-2745-8","article-title":"Malignant mesothelioma of the pleura with desmoplastic histology: a case series and literature review","volume":"16","author":"Hashimoto","year":"2016","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.anndiagpath.2022.152004_bb0165","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1084\/jem.20111653","article-title":"TGF-beta synergizes with defects in the hippo pathway to stimulate human malignant mesothelioma growth","volume":"209","author":"Fujii","year":"2012","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.anndiagpath.2022.152004_bb0170","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/path.4377","article-title":"Connective tissue growth factor and beta-catenin constitute an autocrine loop for activation in rat sarcomatoid mesothelioma","volume":"233","author":"Jiang","year":"2014","journal-title":"J Pathol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2022.152004_bb0175","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF00679991","article-title":"Collagenase in the immunohistochemical demonstration of laminin, fibronectin and factor VIII\/RAg in nervous tissue after fixation","volume":"80","author":"Mauro","year":"1984","journal-title":"Histochemistry"},{"issue":"5","key":"10.1016\/j.anndiagpath.2022.152004_bb0180","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0046-8177(86)80042-9","article-title":"Keratin and epithelial membrane antigen immunoreactivity in nonneoplastic fibrous pleural lesions: implications for the diagnosis of desmoplastic mesothelioma","volume":"17","author":"Epstein","year":"1986","journal-title":"Hum Pathol"},{"key":"10.1016\/j.anndiagpath.2022.152004_bb0185","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1186\/1756-0500-6-542","article-title":"Evaluating real-time immunohistochemistry on multiple tissue samples, multiple targets and multiple antibody labeling methods","volume":"6","author":"Dubois","year":"2013","journal-title":"BMC Res Notes"},{"issue":"4","key":"10.1016\/j.anndiagpath.2022.152004_bb0190","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s40139-018-0179-5","article-title":"Tumor pre-analytics in molecular pathology: impact on protein expression and analysis","volume":"6","author":"Neumeister","year":"2018","journal-title":"Curr Pathobiol Rep"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109291342200106X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109291342200106X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:35:29Z","timestamp":1761078929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109291342200106X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":38,"alternative-id":["S109291342200106X"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2022.152004","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenges and limitation of MTAP immunohistochemistry in diagnosing desmoplastic mesothelioma\/sarcomatoid pleural mesothelioma with desmoplastic features","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2022.152004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152004"}}